FDA — Fidia SpA Balance Sheet
0.000.00%
- €3.00m
- €8.14m
- €17.49m
- 28
- 82
- 11
- 30
Annual balance sheet for Fidia SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.85 | 5.27 | 4.87 | 3.17 | 1.67 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.37 | 8.57 | 7.07 | 7.44 | 5.82 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24.2 | 27.4 | 22.4 | 21.9 | 19.5 |
| Net Property, Plant And Equipment | 11.2 | 10 | 9.33 | 8.24 | 7.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 38.5 | 40.5 | 34 | 32.2 | 28.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 27.5 | 32.6 | 19.1 | 25.6 | 23.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 38.6 | 42.8 | 28 | 29 | 25.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -0.117 | -2.33 | 5.97 | 3.22 | 2.94 |
| Total Liabilities & Shareholders' Equity | 38.5 | 40.5 | 34 | 32.2 | 28.3 |
| Total Common Shares Outstanding |